Coronavirus-Disrupted Drug Firm's $12M Ch. 11 Loan Gets OK

A Delaware bankruptcy judge signed off Thursday on up to $12 million in post-petition financing for diabetes drug technology company Valeritas Holdings Inc., which cited the coronavirus outbreak's impact on its...

Already a subscriber? Click here to view full article